噬菌体疗法:抗生素耐药性的潜在解决方案

Chirag Choudhary
{"title":"噬菌体疗法:抗生素耐药性的潜在解决方案","authors":"Chirag Choudhary","doi":"10.51627/pghr.2021.08.00071","DOIUrl":null,"url":null,"abstract":"The idea of using a virus to kill bacteria may seem counterintuitive, but it may be the future of treating bacterial infections. Before the COVID-19 pandemic, one of the most frightening biological agents were so-called “superbugs” – antibiotic resistant bacteria – which could not be treated with conventional therapeutics. When antibiotics were first developed, they were hailed as a panacea. A panacea they were not.","PeriodicalId":310759,"journal":{"name":"The Pre-Collegiate Global Health Review","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phage Therapy: A Potential Solution for Antibiotic Resistance\",\"authors\":\"Chirag Choudhary\",\"doi\":\"10.51627/pghr.2021.08.00071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The idea of using a virus to kill bacteria may seem counterintuitive, but it may be the future of treating bacterial infections. Before the COVID-19 pandemic, one of the most frightening biological agents were so-called “superbugs” – antibiotic resistant bacteria – which could not be treated with conventional therapeutics. When antibiotics were first developed, they were hailed as a panacea. A panacea they were not.\",\"PeriodicalId\":310759,\"journal\":{\"name\":\"The Pre-Collegiate Global Health Review\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Pre-Collegiate Global Health Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51627/pghr.2021.08.00071\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Pre-Collegiate Global Health Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51627/pghr.2021.08.00071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

用病毒杀死细菌的想法似乎有悖常理,但它可能是治疗细菌感染的未来。在2019冠状病毒病大流行之前,最可怕的生物制剂之一是所谓的“超级细菌”,即耐抗生素细菌,无法用传统疗法治疗。当抗生素最初被开发出来时,它们被誉为灵丹妙药。他们不是灵丹妙药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Phage Therapy: A Potential Solution for Antibiotic Resistance
The idea of using a virus to kill bacteria may seem counterintuitive, but it may be the future of treating bacterial infections. Before the COVID-19 pandemic, one of the most frightening biological agents were so-called “superbugs” – antibiotic resistant bacteria – which could not be treated with conventional therapeutics. When antibiotics were first developed, they were hailed as a panacea. A panacea they were not.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信